Insights from ECTRIMS 2025, including anticipated presentations, key takeaways, and how emerging research on DMTs in RRMS may ...

Patient preference studies (research into what patients value in their treatment) are increasingly used to inform drug ...

Disclaimer: This article has been written by Renata M Barnes, a current Law Student. The content is provided for ...

The physicality of football can't be understated. The full contact display is both the games appeal and its danger. Sometimes ...

Learn the key differences between government and private health insurance in India. Explore their definitions, types, ...

The global DNA vaccine market valued at USD 590 million in 2025, it is projected to reach nearly USD 1041.68 million by 2034, ...

State pensioners with certain health conditions can get an extra cash boost worth up to £5,740.80 per year from the ...

Pipeline Insight, 2025 ” explores a dynamic portfolio of emerging therapies poised to redefine management. Next-generation ...

Attendance Allowance and Pension Age Disability Payment are providing extra financial support for over 1.7 million pensioners ...

Detailed price information for Neurosense Therapeutics Ltd (NRSN-Q) from The Globe and Mail including charting and trades.

Leading KOLs to discuss the unmet needs and current treatment landscapes of idiopathic inflammatory myopathy (IIM), ulcerative colitis (UC), ...